当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 资产负债表

益佰制药

(600594)

  

流通市值:33.34亿  总市值:33.34亿
流通股本:7.92亿   总股本:7.92亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金593,695,601.81695,146,756.66457,074,557.37521,007,309.87
  应收票据及应收账款378,549,822.5410,986,471.31537,542,735.57528,936,121.87
  其中:应收票据204,412,969.62220,189,595.8303,725,854.59337,574,641.63
        应收账款174,136,852.88190,796,875.51233,816,880.98191,361,480.24
  预付款项23,647,927.9422,412,623.4120,093,259.8913,747,641.74
  其他应收款合计30,798,884.2221,140,407.3221,263,944.5219,229,782.13
  其中:应收利息32,591.03---
  存货545,495,239.8571,511,212.81592,276,091.04607,774,905.96
  其他流动资产57,820,739.4257,371,202.8757,038,076.9959,330,333.32
  流动资产合计1,630,008,215.691,778,568,674.381,685,288,665.381,750,026,094.89
非流动资产:
  长期股权投资34,703,753.7934,588,846.7834,975,402.5335,101,388.03
  其他权益工具投资1,290,618.611,330,862.511,312,880.511,312,880.51
  固定资产1,476,529,492.011,533,935,870.961,568,043,725.421,602,546,475.65
  在建工程6,303,210.374,472,266.086,964,634.08699,426.57
  生产性生物资产16,597,724.1215,510,435.5215,403,025.5415,286,302.46
  使用权资产23,904,263.225,775,467.9627,646,672.7229,517,877.48
  无形资产309,700,848.79315,187,760.09315,596,640.85319,558,174.21
  商誉131,262,741.12131,262,741.12131,262,741.12131,262,741.12
  长期待摊费用89,959,878.8394,830,295.7197,565,779.33103,469,961.57
  递延所得税资产100,701,036.1298,582,418.1593,368,355.2390,342,190.82
  其他非流动资产17,226,738.9318,275,899.2217,474,286.0220,577,728.17
  非流动资产合计2,208,180,305.892,273,752,864.12,309,614,143.352,349,675,146.59
  资产总计3,838,188,521.584,052,321,538.483,994,902,808.734,099,701,241.48
流动负债:
  短期借款413,894,610.61510,911,907.83405,952,683.38380,928,986.1
  应付票据及应付账款91,684,492.89100,722,423.99113,928,580.08124,483,297.23
        应付账款91,684,492.89100,722,423.99113,928,580.08124,483,297.23
  合同负债21,012,907.9335,630,377.5624,459,061.827,124,413.57
  应付职工薪酬35,953,417.131,644,724.4329,302,135.7645,575,128.4
  应交税费24,368,447.8724,794,489.6129,494,935.4322,236,961.61
  其他应付款合计78,635,196.1682,074,892.3794,935,200.83109,773,639.89
  其中:应付利息171,203.52171,203.52171,203.52171,203.52
  一年内到期的非流动负债202,011,659.75202,419,148.74213,498,894.45235,089,377.73
  其他流动负债875,995.472,617,914.272,773,583.143,800,686.87
  流动负债合计868,436,727.78990,815,878.8914,345,074.87949,012,491.4
非流动负债:
  长期借款229,558,002.95249,986,836.78249,996,836.78307,516,836.78
  租赁负债20,650,392.7920,570,171.8920,774,033.9922,905,549.85
  长期应付款80,000,00080,000,00083,466,815.7483,877,534.76
  预计负债59,497.51189,875.48307,540.05899,991.93
  递延收益90,776,664.0593,514,674.2597,298,517.8194,639,954.63
  递延所得税负债33,243,435.4433,478,217.5134,031,525.5734,738,580.68
  非流动负债合计454,287,992.74477,739,775.91485,875,269.94544,578,448.63
  负债合计1,322,724,720.521,468,555,654.711,400,220,344.811,493,590,940.03
所有者权益(或股东权益):
  实收资本(或股本)791,927,400791,927,400791,927,400791,927,400
  资本公积653,836,676.92653,836,676.92653,836,676.92653,836,676.92
  减:库存股25,004,481.1425,004,481.1425,004,481.1425,004,481.14
  其他综合收益429,569.42459,752.34446,265.84446,265.84
  盈余公积314,569,579.33314,569,579.33314,569,579.33314,569,579.33
  未分配利润667,420,393.75734,080,957.95744,597,296.08753,983,015.54
  归属于母公司股东权益合计2,403,179,138.282,469,869,885.42,480,372,737.032,489,758,456.49
  少数股东权益112,284,662.78113,895,998.37114,309,726.89116,351,844.96
  股东权益合计2,515,463,801.062,583,765,883.772,594,682,463.922,606,110,301.45
  负债和股东权益合计3,838,188,521.584,052,321,538.483,994,902,808.734,099,701,241.48
公告日期2025-10-302025-08-212025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑